Why Albireo Pharma Stock Is Skyrocketing Today
The company reported positive data from a clinical trial.
A specialty pharmaceutical company, which focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis.
The company reported positive data from a clinical trial.
ALBO earnings call for the period ending June 30, 2020.
ALBO earnings call for the period ending March 31, 2020.
ALBO earnings call for the period ending December 31, 2019.
ALBO earnings call for the period ending September 30, 2019.
ALBO earnings call for the period ending June 30, 2019.
ALBO earnings call for the period ending March 31, 2019.
ALBO earnings call for the period ending December 31, 2018.
We'll know soon enough if Biodel's BIOD-123 has what it takes.
Should you be dumping this stock, too?